SCARPA, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.224
AS - Asia 1.253
EU - Europa 813
SA - Sud America 299
AF - Africa 220
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 9
Totale 5.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.074
SG - Singapore 438
HK - Hong Kong 304
CN - Cina 237
BR - Brasile 206
IT - Italia 162
NL - Olanda 103
DE - Germania 87
FR - Francia 49
FI - Finlandia 42
GB - Regno Unito 41
RU - Federazione Russa 41
PL - Polonia 36
VN - Vietnam 32
SE - Svezia 30
IN - India 23
CA - Canada 21
AT - Austria 18
AR - Argentina 16
IE - Irlanda 15
PE - Perù 15
ES - Italia 14
CI - Costa d'Avorio 13
EC - Ecuador 13
KG - Kirghizistan 13
ZA - Sudafrica 13
LC - Santa Lucia 12
BE - Belgio 11
CO - Colombia 11
ID - Indonesia 11
MA - Marocco 11
AU - Australia 10
BY - Bielorussia 10
JP - Giappone 10
KR - Corea 10
PS - Palestinian Territory 10
TR - Turchia 10
UA - Ucraina 10
BB - Barbados 9
BD - Bangladesh 9
BG - Bulgaria 9
CH - Svizzera 9
DO - Repubblica Dominicana 9
JM - Giamaica 9
MX - Messico 9
PA - Panama 9
SA - Arabia Saudita 9
TJ - Tagikistan 9
DK - Danimarca 8
GR - Grecia 8
HR - Croazia 8
IQ - Iraq 8
LB - Libano 8
MW - Malawi 8
MZ - Mozambico 8
NZ - Nuova Zelanda 8
PH - Filippine 8
PR - Porto Rico 8
SO - Somalia 8
TN - Tunisia 8
VE - Venezuela 8
AL - Albania 7
AO - Angola 7
BA - Bosnia-Erzegovina 7
CL - Cile 7
EG - Egitto 7
GT - Guatemala 7
HU - Ungheria 7
IL - Israele 7
IR - Iran 7
IS - Islanda 7
JO - Giordania 7
LY - Libia 7
ME - Montenegro 7
NC - Nuova Caledonia 7
NE - Niger 7
PY - Paraguay 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
BO - Bolivia 6
CR - Costa Rica 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
EE - Estonia 6
GA - Gabon 6
GE - Georgia 6
LA - Repubblica Popolare Democratica del Laos 6
LV - Lettonia 6
ML - Mali 6
PG - Papua Nuova Guinea 6
PK - Pakistan 6
PT - Portogallo 6
RO - Romania 6
TT - Trinidad e Tobago 6
XK - ???statistics.table.value.countryCode.XK??? 6
YT - Mayotte 6
ZM - Zambia 6
AZ - Azerbaigian 5
BF - Burkina Faso 5
BS - Bahamas 5
Totale 5.625
Salva come PNG Salva come JPEG
Città #
Fairfield 519
Ashburn 339
Hong Kong 297
Singapore 288
Chandler 250
Woodbridge 205
Seattle 201
Houston 195
Cambridge 180
Santa Clara 131
Wilmington 127
Beijing 92
Ann Arbor 75
Boardman 73
San Diego 55
Medford 41
Princeton 40
Los Angeles 33
Des Moines 30
Helsinki 30
Frankfurt am Main 29
Padova 29
Munich 27
Roxbury 27
Bytom 24
New York 19
Hefei 18
Milan 16
Nanjing 16
Buffalo 14
Hanoi 14
São Paulo 13
Abidjan 12
Bishkek 12
Castries 12
Amsterdam 11
Dallas 11
Vienna 11
Ho Chi Minh City 10
Verona 10
Aprilia 9
Dublin 9
Dushanbe 9
San Francisco 9
Bridgetown 8
Brooklyn 8
Chicago 8
Düsseldorf 8
Kingston 8
Lima 8
Nuremberg 8
Panama City 8
Villafranca Padovana 8
Amman 7
Boston 7
Melbourne 7
Noumea 7
Reykjavik 7
Rio de Janeiro 7
Seoul 7
Shenyang 7
Turku 7
Athens 6
Atlanta 6
Bamako 6
Cape Town 6
Chennai 6
Guangzhou 6
Guayaquil 6
Johannesburg 6
Libreville 6
Lusaka 6
Maputo 6
Niamey 6
Salt Lake City 6
San Juan 6
Sofia 6
Tirana 6
Tokyo 6
Tunis 6
Warsaw 6
Baghdad 5
Baku 5
Bangkok 5
Budapest 5
Curitiba 5
Djibouti 5
Hargeisa 5
Hebei 5
Kingstown 5
Lilongwe 5
Managua 5
Minsk 5
Montevideo 5
Montreal 5
Nairobi 5
Nassau 5
Podgorica 5
Port Moresby 5
Portsmouth 5
Totale 3.916
Salva come PNG Salva come JPEG
Nome #
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 199
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 181
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma 151
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 151
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 146
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 146
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 145
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 144
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 142
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 141
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 136
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 129
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 125
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: Correlation of expression, chromosomal status and epigenetic changes 122
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 121
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 121
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: A systematic review and meta-Analysis 120
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 116
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 109
New genomic landscapes and therapeutic targets for biliary tract cancers 107
Prognostic impact of proliferation for resected early stage ‘pure’ invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 106
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 106
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study 106
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis 100
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice 98
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 96
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 96
Malignant epithelial/exocrine tumors of the pancreas 96
Inflammatory and tumor-like lesions of the pancreas 95
Genomic Characterization of Biliary Tract Cancers Identifies Driver Genes and Predisposing Mutations 91
Comparative Lesions Analysis Through a Targeted Sequencing Approach 91
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 88
PBRM1 loss is a late event during the development of cholangiocarcinoma 87
Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells 83
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 80
Exosomal miRNA signatures of pancreatic lesions 79
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 78
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 77
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 72
Genomic characterization of hepatoid tumors: context matters 72
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 70
Molecular biology of neuroendocrine tumors 64
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 62
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 62
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 61
European evidence-based guidelines on pancreatic cystic neoplasms 59
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 57
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 56
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 55
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 55
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 54
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution 50
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 49
Real-world data on NGS diagnostics: A survey from the Italian Society of Pathology (SIAPeC) NGS Network 49
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 47
Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas 45
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 44
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 44
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 43
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 43
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 42
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 41
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 38
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 38
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 36
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 36
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 36
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 29
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 25
Totale 5.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.567
article - articoli 25.198
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 369
Totale 51.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021475 0 0 30 45 12 9 45 57 55 124 81 17
2021/2022635 19 86 94 36 30 8 66 63 32 11 52 138
2022/2023466 87 58 11 64 58 47 2 34 55 25 19 6
2023/2024329 6 39 43 43 18 38 35 4 16 11 40 36
2024/20251.745 15 119 89 46 202 52 93 158 119 140 287 425
2025/20261.308 303 421 584 0 0 0 0 0 0 0 0 0
Totale 5.939